Hematologic Aspects of Pregnancy

Medical Complications During Pregnancy

Volumn , Issue , 2004, Pages 69-86

  Duffy, Thomas P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903082270     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0435-0.50008-0     Document Type: Chapter

References (184)

1. Okuyana T, Tawada T, Furuya H, Villee CA The role of transferrin and ferritin in the fetal-maternal-placental unit. Am J Obstet Gynecol 1995, 152:344.
2. Schwartz WJ III, Thurnau GR Iron deficiency anemia in pregnancy. Clin Obstet Gynecol 1995, 38:443.
3. Ballegeer V, Mombaerts P, Declerk PJ, et al. Fibrinogen response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy. Thromb Haemost 1987, 58:1032.
4. Lecander I, Astedt B Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986, 62:221.
5. Roberts D, Schwartz RS Clotting and hemorrhage in the placenta-a delicate balance. N Engl J Med 2002, 347:57.
6. Williams MD, Wheby MS Anemia in pregnancy. Med Clin North Am 1992, 76:631.
7. Clark MR, Shohet SB Red cell senescence. Clin Haematol 1985, 14:223.
8. Red Blood Cell Aging 1991, Plenum Press, New York. M. Magnani, A. DeFlora (Eds.).
9. Harstad TW, Mason RA, Cox SM Serum erythropoietin quantitation in pregnancy using an enzyme-linked immunoassay. Am J Perinatol 1992, 9:233.
10. Solano FX, Couricell RB Folate deficiency presenting as pancytopenia in pregnancy. Am J Obstet Gynecol 1986, 154:1117.
11. Hytten F Blood volume changes in normal pregnancy. Clin Haematol 1985, 14:601.
12. Horn E Iron and folate supplements during pregnancy. BMJ 1988, 297:1325.
13. van Besien K, Tricot G, Golichowski A, et al. Pregnancy-associated aplastic anemia. Eur J Haematol 1991, 47:253.
14. Berliner N, Duffy T, Abelson H Approach to the adult and child with anemia. Hematology: Basic Principles and Practice 1995, 468-483. Churchill Livingstone, New York. 2nd ed. R. Hoffman, E. Benz, S. Shattil (Eds.).
15. Thompson WG Red cell distribution width in alcohol abuse and iron deficiency anemia [Letter]. JAMA 1992, 267:1071.
16. Delpapa EH, Edelstone DI, Milley JR, et al. Effects of chronic maternal anemia on systemic and uteroplacental oxygenation in near term pregnant sheep. Am J Obstet Gynecol 1992, 166:1007.
17. Godfrey KM, Redman CW, Barker DJ, et al. The effect of maternal anemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol 1991, 98:886.
18. Klebanoff MA, Shiono PH, Berendes HW, et al. Facts and artifacts about anemia and pre-term delivery. JAMA 1989, 162:511.
19. Rushton DH, Ramsay ID, Gilkes JJ, et al. Ferritin and fertility [Letter]. Lancet 1991, 337:1554.
20. Pietrzik K, Prinz R, Reusch K, et al. Folate status and pregnancy outcomes. Ann N Y Acad Sci 1992, 669:371.
21. Duffy TP Iron deficiency. The Fundamentals of Clinical Hematology 1993, 17-26. Johns Hopkins University Press, Baltimore. 3rd ed. J. Spivak, E. Eichner (Eds.).
22. Foulkes J, Goldie DJ The use of ferritin to assess the need for iron supplements in pregnancy. J Obstet Gynecol 1982, 3:11.
23. Guldholt IS, Trolle BG, Hvidman LE Iron supplementation during pregnancy. Acta Obstet Gynecol Scand 1991, 70:9.
24. Romslo I, Haram K, Sagen V, et al. Iron requirements in normal pregnancy as assessed by serum ferritin, serum transferring saturation and erythrocyte protoporphyrin determinations. Br J Obstet Gynaecol 1988, 90:101.
25. Punnonen K, Irjala K, Rajamaki A Serum transferring receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997, 89:1052.
26. Vogt C Iron requirements of pregnancy. Clin Issues Perinat Womens Health Nurs 1991, 2:364.
27. Faich G, Strobos J Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans. Am J Kidney Dis 1999, 33:464.
28. Bayoumeu F, Subiran-Buisset C, Baka NE, et al. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol 2002, 186:518.
29. Scholl TO, Hediger ML, Fischer RL, et al. Anemia vs. iron deficiency: Increased risk of pre-term delivery in a prospective study. Am J Clin Nutr 1992, 55:985.
30. Steer P The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol 1992, 99:271.
31. Crosby WH Pica: A compulsion caused by iron deficiency. Br J Haematol 1976, 34:341.
32. Woywodt A, Kiss A Geophagia: The history of earth-eating. J R Soc Med 2002, 95:143.
33. Horner RD, Lackey J, Kolasa K, et al. Pica practices of pregnant women. J Am Diet Assoc 1991, 91:34.
34. Smulian JC, Motiwala S, Sigman RK Pica in a rural obstetric population. South Med J 1995, 88:1236.
35. Barton JR, Riely CA, Sibai BM Baking powder pica mimicking preeclampsia. Am J Obstet Gynecol 1992, 167:98.
36. Campbell BA Megaloblastic anemia in pregnancy [Review]. Clin Obstet Gynecol 1995, 38:455.
37. 12 deficient breast-fed infant of a strict vegetarian. N Engl J Med 1978, 299:17.
38. March of Dimes Folic acid supplementation and prevention of birth defects. J Nutr 2002, 132:2356S.
39. Ali SA, Economides DL Folic acid supplementation. Obstet Gynecol 2000, 12:507.
40. Bunn H, Forget B Hemoglobin-Molecular, Genetic, and Clinical Aspects 1986, WB Saunders, Philadelphia.
41. VanEnk A, Vicshers G, Jansen W, et al. Maternal death due to sickle cell chronic lung disease. Br J Obstet Gynaecol 1992, 99:162.
42. Sarjeant G Sickle Cell Disease 1992, Oxford University Press, New York.
43. Perry KG, Morrison JC The diagnosis and management of hemoglobinopathies during pregnancy. Semin Perinatol 1990, 14:90.
44. Oklene-Frempoing K, Smith-Whitley K Use of hydroxyurea in children with sickle cell disease. Semin Hematol 1977, 34:30.
45. Day NS, Tadin M, Christiano AM, et al. Rapid prenatal diagnosis of sickle cell diseases using oligonucleotide ligation assay coupled with laser-induced capillary fluorescence detection. Prenat Diagn 2002, 22:686.
46. Phillips OP, Elias S Prenatal diagnosis of hematologic disorders. Clin Obstet Gynecol 1995, 38:558.
47. Smith JA, Espeland M, Bellevue R, et al. Pregnancy in sickle cell disease: Experience of the cooperative study of sickle cell disease. Obstet Gynecol 1996, 87:199.
48. Koshy M, Burd L, Wallace D, et al. Prophylactic red cell transfusions in pregnant patients with sickle cell disease. N Engl J Med 1988, 319:1447.
49. Sun PM, Wilburn W, Raynor BD, Jamieson D Sickle cell disease in pregnancy: Twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol 2001, 184:1127.
50. Danielson CF The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002, 6:24.
51. Higgs DR, Wood WG, Jarman AP, et al. The alpha-thalassemias. Ann N Y Acad Sci 1990, 612:15.
52. Kazazian HH, Dowling LE, Boehm CD, et al. Gene defects in betathalassemia and their prenatal diagnosis. Ann N Y Acad Sci 1990, 612:1.
53. VanderWeyden MB, Foug H, Hallam LI, et al. Red cell ferritin and iron overload in heterozygous beta-thalassemia. Am J Hematol 1989, 30:201.
54. Cao A, Saba L, Galanello R, Rosatelli M Molecular diagnosis and carrier screening for beta thalassemia. JAMA 1997, 278:1273.
55. Fischel-Ghodsian N Prenatal diagnosis of hemoglobinopathies. Clin Perinatol 1990, 17:811.
56. Kilpatrick SJ, Laros RK Thalassemia in pregnancy. Clin Obstet Gynecol 1995, 38:485.
57. Kumar RM, Rizk DE, Khuranna A Beta-thalassemia major and successful pregnancy. J Reprod Med 1997, 42:294.
58. Mordel N, Birkenfeld A, Goldfarb AN, et al. Successful full-term pregnancy in homozygous beta-thalassemia major. Obstet Gynecol 1989, 73:837.
59. Leung CF, Lao TT, Chang AM Effect of folate supplement on pregnant women with beta-thalassemia minor. Eur J Obstet Gynecol Reprod Biol 1989, 33:209.
60. O(D) immune globulin IV for prevention of Rh isoimmunization and for treatment of ITP. Med Lett Drugs Ther 1996, 38:6.
61. Bowman JM Antenatal suppression of Rh alloimmunization. Clin Obstet Gynecol 1991, 34:296.
62. Chitkara U, Bussel J, Alvarez N, et al. High-dose intravenous gamma globulin: Does it have a role in the treatment of severe erythroblastosis fetalis?. Obstet Gynecol 1990, 76:703.
63. Hadley AG Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transpl Immunol 2002, 10:191.
64. Tannirandorn Y, Rodeck CH Management of immune hemolytic disease in the fetus. Blood Rev 1991, 5:1.
65. Management of isoimmunization in pregnancy. ACOG Technical Bulletin number 148-October 1990. Int J Gynaecol Obstet 1992, 37:57.
66. Gollin YG, Copel JA Management of the Rh-sensitized mother. Clin Perinatol 1995, 22:545.
67. Stockman J Overview of the state of the art of Rh disease: History, current clinical management and recent progress. J Pediatr Hematol Oncol 2001, 23:554.
68. Stetyn DW, Pattinson RC, Odendaal HJ Amniocentesis-still important in the management of severe rhesus incompatibility. S Afr Med J 1992, 82:321.
69. Kanhai HH Management of severe red cell immunization in pregnancy. Eur J Obstet Gynecol Reprod Biol 1991, 42:S90.
70. Aitchison RG, Marsh JC, Hows JM, et al. Pregnancy associated aplastic anemia: A report of 5 cases and review of current management. Br J Haematol 1989, 73:541.
71. Pajor A, Kelemen E, Szakacs Z, Lehoczky D Pregnancy in idiopathic aplastic anemia (report of 10 patients). Eur J Obstet Gynecol Reprod Biol 1992, 45:19.
72. Tichelli A, Socie G, Marsh J, Barge R, et al. Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann Intern Med 2002, 137:164.
73. Alter BP, Frissora CL, Halperin DS, et al. Fanconi's anemia and pregnancy. Br J Haematol 1991, 77:410.
74. Alter BP, Kumar M, Lockhart LL, et al. Pregnancy in bone marrow failure syndromes: Diamond-Blackfan anaemia and Shwachman-Diamond syndrome. Br J Haematol 1999, 107:49.
75. Fujiwaki R, Hata T, Hata K, et al. Effective treatment of drug-induced agranulocytosis using recombinant human granulocyte colony stimulating factor in pregnancy. Gynecol Obstet Invest 1995, 40:276.
76. Ball SE The modern management of severe aplastic anemia. Br J Haematol 2000, 110:41.
77. Young N Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988, 25:159.
78. Brown KE, Young NS Human parvovirus B19: Pathogenesis of disease. Monographs in Virology, vol 20: Human Parvovirus B19 1997, 105-119. Karger, Basel, Switzerland. L.J. Anderson, N.S. Young (Eds.).
79. Nunoue T, Kusuhara K, Hara T Human fetal infection with parvovirus B19 maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002, 21:1133.
80. Banavali SD, Parikh PM, Charak BS, et al. Corticosteroid-responsive pure red cell aplasia in rheumatoid arthritis and its association with pregnancy. Am J Hematol 1989, 31:58.
81. Fisch P, Handgretinger R, Schaefer HE Pure red cell aplasia. Br J Haematol 2000, 111:1010.
82. Rosse WF Paroxysmal nocturnal hemoglobinuria and decay-accelerating factor. Annu Rev Med 1990, 41:431.
83. Schultz DR Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria. Am J Med 1989, 87:22.
84. Solal-Celigney P, Tertian G, Fernandez H, et al. Pregnancy and paroxysmal nocturnal hemoglobinuria. Arch Intern Med 1988, 148:593.
85. Ray JG, Burrows RF, Gusberg JS PNH and the risk of venous thrombosis: Review and recommendations for management of the pregnant and nonpregnant patient. Haemostasis 2000, 30:103.
86. Sholar PW The continuing problem of thrombosis in paroxysmal nocturnal hemoglobinuria. N Y State J Med 1992, 92:88.
87. Imai A, Takagi H, Kawabata I, et al. Successful pregnancy in a patient with paroxysmal nocturnal hemoglobinuria. Arch Gynecol Obstet 1989, 246:121.
88. Sirchia G, Zanell A Transfusion of PNH patients. Transfusion 1990, 30:479.
89. Ferfusen JE II, Ueland K, Aronson W Polycythemia rubra vera and pregnancy. Obstet Gynecol 1983, 62:16S.
90. Spivak JL The optimal management of PCV. Br J Haematol 2002, 116:243.
91. Baer MR, Ozer H, Foon KA Interferon-alpha therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. Br J Haematol 1992, 81:167.
92. Griesshammer M, Heimpel H, Pearson TC Essential thrombocythemia and pregnancy. Leuk Lymphoma 1996, 22(Suppl 1):57.
93. Wright CA, Tefferi A A single institutional experience with 43 pregnancies in essential thrombocythemia [Review]. Eur J Haematol 2001, 66:152.
94. Delage R, Demers C, Cantin G, Roy J Treatment of essential thrombocythemia during pregnancy with interferon-alpha. Obstet Gynecol 1996, 87:814.
95. Tefferi A, Solberg LA, Silverstein MN A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000, 109:141.
96. Fitzgerald D, Rowe JM, Heal J Leukapheresis for control of chronic myelogenous leukemia during pregnancy. Am J Hematol 1986, 22:213.
97. Doll DC, Ringenberg QS, Yarbro JW Antineoplastic agents and pregnancy. Semin Oncol 1989, 16:337.
98. Newton I, Charbord P, Schaal JD, et al. Toward cord blood banking: Density separation and cryopreservation of cord blood progenitors. Exp Hematol 1993, 21:671.
99. Ward F, Weiss R Lymphoma and pregnancy. Semin Oncol 1989, 16:397.
100. Pejovic T, Schwartz P Leukemia. Clin Obstet Gynecol 2002, 45:866.
101. Caligiuri M, Mayer R Pregnancy and leukemia. Semin Oncol 1989, 16:388.
102. Incerpi MH, Miller DA, Posen R, Byrne J All- trans-retinoic acid for treatment of acute promyelocytic leukemia in pregnancy. Obstet Gynecol 1997, 89:826.
103. Gewirtz AM Megarkaryocytopoiesis: The state of the art. Thromb Haemost 1995, 74:204.
104. Rinder HM, Munz UJ, Ault KA, et al. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993, 117:606.
105. Romero R, Mazor M, Lockwood CJ, et al. Clinical significance, prevalence and natural history of thrombocytopenia in pregnancy induced hypertension. Am J Perinatol 1989, 6:32.
106. Kelton JG ITP complicating pregnancy [Review]. Blood 2002, 16:43.
107. McCrae K, Cines D Thrombotic microangiopathy during pregnancy. Semin Hematol 1997, 34:148.
108. Kunicki T, Newman P The molecular immunology of human platelet proteins. Blood 1992, 80:1386.
109. Crowther MA, Burrows RF, Ginsberg J, Kelton JG Thrombocytopenia in pregnancy: Diagnosis, pathogenesis and management. Blood Rev 1996, 10:8.
110. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996, 88:3.
111. Kelton JG, Powers PJ, Carter CJ A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 1982, 60:1050.
112. Beardsley DS Platelet autoantigens: Identification and characterization using immunoblotting. Blut 1989, 59:47.
113. Berchtold P, Wenger M Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment. Blood 1993, 81:1246.
114. Keifel V, Santoso S, Kaufmann E, et al. Autoantibodies against platelet glycoprotein Ib/IX: A frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991, 79:256.
115. Burrows RF Platelet disorders in pregnancy. Curr Opin Obstet Gynecol 2001, 13:115.
116. Samuels P, Bussel JB, Braitman LE, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed thrombocytopenia. N Engl J Med 1990, 323:229.
117. Garmel SH, Craigo SD, Morin LM, et al. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn 1995, 15:439.
118. Dan U, Barkai G, David B, et al. Management of labor in patients with idiopathic thrombocytopenic purpura. Gynecol Obstet Invest 1989, 27:193.
119. Aster RH "Gestational" thrombocytopenia: A plea for conservative management. N Engl J Med 1990, 323:264.
120. Copplestone JA Asymptomatic thrombocytopenia developing during pregnancy (gestational thrombocytopenia): A clinical study. Q J Med 1992, 8:593.
121. Eisenberg GM Antiphospholipid syndrome: The reality and implications. Hosp Prac 1992, 27:119.
122. Minakami H, Yamada H, Suzuki S Gestational thrombocytopenia and pregnancy-induced antithrombin deficiency: Progenitors to the development of the HELLP syndrome and acute fatty liver of pregnancy. Semin Thromb Hemost 2002, 28:515.
123. Redman CW Platelets and the beginning of pre-eclampsia. N Engl J Med 1990, 323:478.
124. British Committee for Standards in Haematology General Haematology Task Force Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003, 120:574.
125. Ballem PJ, Buskard N, Wittmann BK, et al. ITP in pregnancy: Use of the bleeding time as an indicator for treatment. Blut 1989, 59:131.
126. Christiaens GC, Neiuwenhuis HK, von Dem Borne AE, et al. Idiopathic thrombocytopenic purpura in pregnancy: A randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 1990, 97:893.
127. Gibson J, Laird PP, Joshua DE, et al. Very high dose intravenous gammaglobulin in thrombocytopenia of pregnancy. Aust N Z J Med 1989, 19:151.
128. Godeau B, Lesage S, Divine M, et al. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high dose intravenous immunoglobulin. Blood 1993, 82:1415.
129. Anglin BV, Rutherford C, Ramus R, et al. Immune thrombocytopenic purpura during pregnancy: Laparoscopic treatment. JSLS 2001, 5:63.
130. Leduc L, Wheeler JM, Kirshon B, et al. Coagulation profile in severe pre-eclampsia. Obstet Gynecol 1992, 79:14.
131. Weiner CP Preclampsia-eclampsia syndrome and coagulation. Clin Perinatol 1991, 18:713.
132. Saleh AA, Bottoms SF, Farag AM, et al. Markers for endothelial injury, clotting and platelet activation in pre-eclamsia. Arch Gynecol Obstet 1992, 251:105.
133. Weiner CP The mechanism of reduced antithrombin III activity in women with pre-eclampsia. Obstet Gynecol 1988, 72:847.
134. Gaffney PJ, Creighton LJ, Callus M Monoclonal antibodies to crosslinked fibrin degradation products: Evaluation in a variety of clinical conditions. Br J Haematol 1988, 68:91.
135. Rappaport VJ, Hirata G, Yap HK, et al. Antivascular endothelial cell antibodies in severe eclampsia. Am J Obstet Gynecol 1990, 162:138.
136. Haeger M, Unander M, Bengtsson A Complement activation in relation to development of pre-eclampsia. Obstet Gynecol 1991, 78:46.
137. Sibai BM Immunologic aspects of pre-eclampsia. Clin Obstet Gynecol 1991, 34:27.
138. Walsh S Pre-eclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985, 152:335.
139. Schiff S, Ben-Baruch G, Peleg E, et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 1992, 166:624.
140. CLASP A randomised study of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994, 343:619.
141. 2 to prostacyclin in relative high-risk pregnancies. N Engl J Med 1989, 321:351.
142. Subtil D, Goeusse P, Puech F, et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: The Essai Regional Aspirine Mere-Enfant study (Part 1). BJOG 2003, 110:475.
143. Sureau C Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: Results of the Epreda trial. The Epreda Trial Study Group. Eur J Obstet Gynecol Reprod Biol 1991, 41:71.
144. Dildy GA III, Cotton DB Management of severe pre-eclampsia and eclampsia. Crit Care Clin 1991, 7:829.
145. Schrocksnadel H, Sitte B, Stekel-Berger G, et al. Hemolysis in hypertensive disorders of pregnancy. Gynecol Obstet Invest 1992, 34:211.
146. Dotsch J, Hohmann M, Kuhl PG Neonatal morbidity and mortality associated with maternal hemolysis elevated liver enzymes and low platelet syndrome. Eur J Pediatr 1997, 156:389.
147. Fairlie F, Sibai B HELLP syndrome. Haemostasis and Thrombosis in Obstetrics and Gynecology 1992, 203. Chapman & Hall, London. I.A. Greer, A.G. Turpie, C.D. Forbes (Eds.).
148. DeBoer K, Buller H, Ten Cate J, et al. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol 1991, 98:42.
149. Weiner CP Thrombotic microangiopathy in pregnancy and postpartum period. Semin Hematol 1987, 24:119.
150. Schwartz M, Brenner W The obfuscation of eclampsia by thrombotic thrombocytopenic purpura. Am J Obstet Gynecol 1978, 131:18.
151. Rozdinski E, Hertenstein B, Schmeiser T, et al. Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival. Ann Hematol 1992, 64:245.
152. George JN, Sadler JE, Lämmle B Platelets: Thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program) 2002, (1):315-334.
153. McMinn JR, George JN Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apheresis 2001, 16:202.
154. Fausset B, Silver R Congenital disorders of platelet function. Clin Obstet Gynecol 1999, 42:390.
155. Peng TC, Kickler TS, Bell WR, et al. Obstetric complications in a patient with Bernard-Soulier syndrome. Am J Obstet Gynecol 1991, 165:425.
156. Saade G, Homsi R, Seoud M Bernard-Soulier syndrome in pregnancy: A report of four pregnancies in one patient and review of the literature. Eur J Obstet Gynecol Reprod Biol 1991, 40:149.
157. Rick ME, Williams SB, Sacher RA, et al. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood 1987, 69:786.
158. Wax JR, Rosengren S, Spector E, et al. DNA diagnosis and management of Hermansky-Pudlak syndrome in pregnancy. Am J Perinatol 2001, 18:159.
159. Edozian LC, Jip J, Mayers FN Platelet storage pool deficiency in pregnancy. Br J Clin Pract 1995, 49:220.
160. Chediak JR, Alban GM, Maxey B von Willebrand's disease and pregnancy: Management during delivery and outcome of offspring. Am J Obstet Gynecol 1986, 155:618.
161. Nishino M, Nishino S, Sugimoto M, et al. Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2B von Willebrand disease after hemostatic treatment and during pregnancy. Int J Haematol 1996, 64:127.
162. Steinberg MH, Saletaris S, Funt M, et al. Management of factor XI deficiency in gynecologic and obstetric patients. Obstet Gynecol 1986, 68:130.
163. Boda Z, Pfliegler G, Muszbek L, et al. Congenital factor XIII deficiency with multiple benign breast tumors and successful pregnancy with substitutive therapy. Haemostasis 1989, 19:348.
164. Egbring R, Kroniger A, Seitz R Factor XIII deficiency: Pathogenic mechanism and clinical significance [Review]. Semin Thromb Hemost 1996, 22:419.
165. Rigby FB, Nolan TE Inherited disorders of coagulation in pregnancy. Clin Obstet Gynecol 1995, 38:497.
166. Robertson LE, Wasserstrum N, Bazez E, et al. Hereditary factor VII deficiency in pregnancy: Peripartum treatment with factor VII concentrate. Am J Hematol 1992, 40:38.
167. Guy GP, Baxi LV, Hurlet-Jensen A, et al. An unusual complication in a gravida with factor IX deficiency. Obstet Gynecol 1992, 80:502.
168. Greer IA, Lowe GD, Walker JJ, et al. Hemorrhagic problems in obstetrics and gynecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991, 98:909.
169. Lusher JM Screening and diagnosis of coagulation disorders. Am J Obstet Gynecol 1996, 175:778.
170. Richey ME, Gilstrap LC III, Ramin SM Management of disseminated intravascular coagulopathy. Clin Obstet Gynecol 1995, 38:514.
171. Weiner CP The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 1986, 13:705.
172. Romero R, Copel JA, Hobbins JC, et al. Intrauterine fetal demise and hemostatic failure: The fetal death syndrome. Clin Obstet Gynecol 1985, 28:24.
173. Lockwood CJ, Bach R, Guha A, et al. Amniotic fluid containing tissue factor: A potent initiator of coagulation. Am J Obstet Gynecol 1991, 165:1335.
174. Tuffnell DJ Amniotic fluid embolism. Curr Opin Obstet Gynecol 2003, 15:119.
175. Masson RG Amniotic fluid embolism. Clin Chest Med 1992, 13:657.
176. Clark SL Amniotic fluid embolism. Crit Care Clin 1991, 7:877.
177. Kobayashi H, Ohi H, Terao T A simple, noninvasive, sensitive method of diagnosis of amniotic fluid embolism by monoclonal TKH-2 that recognizes NeuAC alpha 2-6 GalNAC. Am J Obstet Gynecol 1993, 168:848.
178. Hardin L, Fox LS, O'Quinn AG Amniotic fluid embolism. South Med J 1991, 84:1046.
179. Twaalfhoven FC, van Roosmalen J, Briet E, et al. Conservative management of placental abruption complicated by severe clotting disorders. Eur J Obstet Gynecol Reprod Biol 1992, 46:25.
180. Mechem CC, Knopp RK, Feldman D Painless abruptio placentae associated with disseminated intravascular coagulation and syncope. Ann Emerg Med 1992, 21:833.
181. Fleming AD Abruptio placentae. Crit Care Clin 1991, 7:865.
182. Pritchard J, Whalley PJ Abortion complicated by Clostridium perfringens infection. Am J Obstet Gynecol 1971, 111:484.
183. Romero R, Duffy TP, Berkowitz R, et al. Prolongation of a preterm pregnancy complicated by death of a single twin in utero and disseminated intravascular coagulation. N Engl J Med 1984, 310:772.
184. Staikowsky F, Blanchin I, Pineat-Vincent F, et al. Inhibitors of factor VIII C and pregnancy: Review of the literature. J Gynecol Obstet Biol Reprod (Paris) 1991, 20:817.